Discussion

Open Access

Discussion

Session: Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Topic: Lipid-Lowering Agents

Speaker: Professor E. Stroes (Amsterdam, NL) Professor S. Nicholls (Melbourne, AU) Professor J. Kastelein (Amsterdam, NL) Professor R. Mehran (New York, US)

Sponsored by PACE-CME – Supported by an unrestricted educational grant from Menarini and NewAmsterdam Pharma

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speakers

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))

39 presentations

0 follower

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

53 presentations

5 followers

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))

34 presentations

6 followers

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

53 presentations

12 followers

4 more presentations in this session

Introduction

Speaker: Professor E. Stroes (Amsterdam, NL)

Access

Slides

Video

Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets

Speaker: Professor S. Nicholls (Melbourne, AU)

Access

Slides

Video

New insights on CETP inhibitors from genetic research and clinical trials

Speaker: Professor J. Kastelein (Amsterdam, NL)

Access

Slides

Video

Exploring the role of novel CETP inhibitors in lipid management

Speaker: Professor R. Mehran (New York, US)

Access

Slides

Video

Access the full session

Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Speakers: Professor E. Stroes, Professor S. Nicholls, Professor J. Kastelein, Professor R. Mehran, Professor E. Stroes...

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources